Q32 Bio Inc. Files Q1 2025 10-Q
Ticker: QTTB · Form: 10-Q · Filed: May 8, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech, debt
TL;DR
Q32 Bio's Q1 2025 10-Q is in: shows preferred stock, convertible debt, and SVB loan details.
AI Summary
Q32 Bio Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Homology Medicines, Inc., reported on its financial status and business operations. Key financial activities include transactions related to preferred stock, convertible debt, and employee stock options. The filing also references a loan and security agreement with Silicon Valley Bank from December 11, 2020.
Why It Matters
This filing provides investors and stakeholders with an update on Q32 Bio's financial health and operational activities for the first quarter of 2025, including details on its capital structure and debt agreements.
Risk Assessment
Risk Level: medium — The company's financial disclosures, including debt and stock arrangements, indicate potential financial risks and complexities typical of a biotechnology firm.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the financial period covered by the 10-Q filing.)
- 2020-12-11 — Loan Agreement Date (Marks the execution date of the loan and security agreement with Silicon Valley Bank.)
Key Players & Entities
- Q32 Bio Inc. (company) — Filer of the 10-Q
- Homology Medicines, Inc. (company) — Former name of Q32 Bio Inc.
- Silicon Valley Bank (company) — Lender in a loan agreement
- 20250331 (date) — End of the reporting period
- 2020-12-11 (date) — Date of loan and security agreement
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
What was Q32 Bio Inc. formerly known as?
Q32 Bio Inc. was formerly known as Homology Medicines, Inc.
What type of financial instruments are mentioned in relation to Q32 Bio's capital structure?
The filing mentions preferred stock, convertible debt, and employee stock options.
Is there any mention of debt financing agreements?
Yes, a loan and security agreement with Silicon Valley Bank dated December 11, 2020, is referenced.
What is the SIC code for Q32 Bio Inc.?
The Standard Industrial Classification (SIC) code for Q32 Bio Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Q32 Bio Inc. (QTTB).